Clinical Trial Update: Anlotinib Plus Chemotherapy as First-line Therapy for Gastrointestinal Tumor Patients With Unresectable Liver Metastasis (ALTER-G-001) [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating anlotinib plus chemotherapy as first-line therapy for gastrointestinal tumors with unresectable liver metastasis (ALTER-G-001).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Tumors

Drugs mentioned

• Anlotinib (anlotinib)

Snippet

Sponsor: Ruijin Hospital | Conditions: Gastrointestinal Tumors | Phase 2 | Status: UNKNOWN